Edward Tenthoff

Stock Analyst at Piper Sandler

(3.03)
# 2,640
Out of 5,044 analysts
179
Total ratings
43.02%
Success rate
0.6%
Average return

Stocks Rated by Edward Tenthoff

Karyopharm Therapeutics
Oct 9, 2025
Reiterates: Overweight
Price Target: $15$12
Current: $5.95
Upside: +101.68%
Camp4 Therapeutics
Sep 15, 2025
Maintains: Overweight
Price Target: $18$12
Current: $3.86
Upside: +210.88%
Alnylam Pharmaceuticals
Aug 1, 2025
Maintains: Overweight
Price Target: $304$449
Current: $442.40
Upside: +1.49%
NextCure
Jul 15, 2025
Maintains: Overweight
Price Target: $36$15
Current: $11.97
Upside: +25.31%
Inovio Pharmaceuticals
Jul 9, 2025
Initiates: Overweight
Price Target: $5
Current: $2.44
Upside: +104.92%
CRISPR Therapeutics AG
Jun 27, 2025
Reiterates: Overweight
Price Target: $105
Current: $61.80
Upside: +69.90%
Sutro Biopharma
Jun 16, 2025
Upgrades: Overweight
Price Target: $2
Current: $1.01
Upside: +98.02%
Biomea Fusion
Jun 3, 2025
Assumes: Overweight
Price Target: $7
Current: $1.36
Upside: +414.71%
Fulcrum Therapeutics
May 29, 2025
Maintains: Overweight
Price Target: $6$9
Current: $9.58
Upside: -6.05%
Arvinas
May 2, 2025
Reiterates: Overweight
Price Target: $24$14
Current: $9.93
Upside: +40.99%
Maintains: Overweight
Price Target: $4$2
Current: $0.58
Upside: +244.83%
Maintains: Overweight
Price Target: $53$48
Current: $23.66
Upside: +102.92%
Reiterates: Overweight
Price Target: $15$24
Current: $16.24
Upside: +47.78%
Reiterates: Overweight
Price Target: $78
Current: $31.70
Upside: +146.06%
Upgrades: Overweight
Price Target: $20$30
Current: $14.51
Upside: +106.75%
Maintains: Overweight
Price Target: $62$45
Current: $40.45
Upside: +11.25%
Reiterates: Overweight
Price Target: $115$69
Current: $24.64
Upside: +180.03%
Maintains: Overweight
Price Target: $104$65
Current: $10.51
Upside: +518.46%
Initiates: Overweight
Price Target: $35
Current: $6.35
Upside: +451.18%
Reiterates: Overweight
Price Target: $20
Current: $1.53
Upside: +1,207.19%
Reiterates: Overweight
Price Target: $3
Current: $1.43
Upside: +109.79%
Maintains: Overweight
Price Target: $8$3
Current: $0.70
Upside: +328.51%
Reiterates: Overweight
Price Target: $16
Current: $12.53
Upside: +27.69%
Upgrades: Overweight
Price Target: $4$6
Current: $1.34
Upside: +349.44%
Maintains: Overweight
Price Target: $6$5
Current: $1.86
Upside: +168.82%
Maintains: Overweight
Price Target: $39$56
Current: $59.99
Upside: -6.65%
Maintains: Overweight
Price Target: $224$248
Current: $30.98
Upside: +700.52%
Initiates: Overweight
Price Target: $90
Current: $3.88
Upside: +2,219.59%
Maintains: Overweight
Price Target: $140$180
Current: $17.49
Upside: +929.16%
Maintains: Overweight
Price Target: $37$44
Current: $17.75
Upside: +147.89%
Maintains: Overweight
Price Target: $76$37
Current: $8.31
Upside: +345.25%
Maintains: Overweight
Price Target: $2,246,640$651,200
Current: $1.43
Upside: +45,698,145.61%
Upgrades: Overweight
Price Target: $250$354
Current: $785.46
Upside: -54.93%
Maintains: Overweight
Price Target: $105$135
Current: $1.77
Upside: +7,527.12%
Maintains: Overweight
Price Target: $261$323
Current: $420.57
Upside: -23.20%
Maintains: Overweight
Price Target: $33$36
Current: $39.39
Upside: -8.61%
Downgrades: Neutral
Price Target: $50$25
Current: $0.97
Upside: +2,477.32%
Initiates: Overweight
Price Target: $150
Current: $1.34
Upside: +11,094.03%
Initiates: Overweight
Price Target: $1,380
Current: $0.57
Upside: +241,835.48%
Upgrades: Overweight
Price Target: n/a
Current: $653.00
Upside: -